Fiche publication
Date publication
septembre 2024
Journal
Inflammatory bowel diseases
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Uzzan M, Georgiev G, Peyrin-Biroulet L, Bouhnik Y, Narula N, Jairath V, Ungaro R, Burisch J, Kirchgesner J, Verstock B, Hussain F, Reinisch W
Lien Pubmed
Résumé
While recruitment rates in inflammatory bowel disease (IBD) trials are continuously decreasing, the underlying reasons are likely multifactorial but remain poorly defined. Screen failure (SF) proportions and causes have not been extensively explored in IBD.
Mots clés
IBD, clinical trials, drug development, screen failure
Référence
Inflamm Bowel Dis. 2024 09 26;:
